• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review.

作者信息

Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vaiva

机构信息

West Kazakhstan Marat Ospanov State Medical University, 030019 Aktobe city, Maresyev str., 68, Kazakhstan.

Institute of Cardiology of Lithuanian University of Health Sciences, Sukileliu 17, Kaunas, LT 50009, Lithuania.

出版信息

Per Med. 2016 Sep;13(5):423-428. doi: 10.2217/pme-2016-0041. Epub 2016 Jun 6.

DOI:10.2217/pme-2016-0041
PMID:29767595
Abstract

We present two clinical cases of acute and subacute coronary artery stent thrombosis in patients treated at the Department of Interventional Cardiology in Aktobe, Kazakhstan. Our results draw attention to the impact of CYP3A41B on the clinical effect of clopidogrel during dual antiplatelet therapy after PCI. The genotyping performed at the Laboratory of Molecular Cardiology of Institute of Cardiology of Lithuanian University of Health Sciences in Lithuania revealed that both patients were homozygous carriers of CYP3A41B*1B. They also were carriers of CYP2C19 loss-of-function *2 or *3 alleles (12 and 13, respectively).

摘要

相似文献

1
Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review.
Per Med. 2016 Sep;13(5):423-428. doi: 10.2217/pme-2016-0041. Epub 2016 Jun 6.
2
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.细胞色素 2C19*17 等位基因变异、血小板聚集、出血事件和氯吡格雷治疗的冠状动脉支架置入患者的支架血栓形成。
Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18.
3
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.CYP2C19*2和CYP2C19*17基因多态性在经皮冠状动脉介入治疗后氯吡格雷反应性中起关键作用:一项药物基因组学研究。
Basic Clin Pharmacol Toxicol. 2017 Jul;121(1):29-36. doi: 10.1111/bcpt.12763. Epub 2017 Mar 14.
4
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.CYP2C19*2 和 CYP2C9*3 等位基因与支架血栓形成相关:一项病例对照研究。
Eur Heart J. 2010 Dec;31(24):3046-53. doi: 10.1093/eurheartj/ehq321. Epub 2010 Sep 10.
5
Clopidogrel Resistance: case reports of CYP2C19 gene variants in suspected coronary stent thrombosis.氯吡格雷抵抗:疑似冠状动脉支架血栓形成中 CYP2C19 基因变异的病例报告。
Heart Lung Circ. 2011 Oct;20(10):657-8. doi: 10.1016/j.hlc.2010.06.1054. Epub 2011 Jan 6.
6
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.除了 CYP2C19*2,CYP2C9*3 变异等位基因与接受择期冠状动脉支架植入术的双联抗血小板治疗患者的氯吡格雷血小板反应性升高相关。
Pharmacogenet Genomics. 2010 Jan;20(1):18-25. doi: 10.1097/FPC.0b013e328333dafe.
7
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.氯吡格雷治疗血小板反应与支架血栓形成风险与对氧磷酶 1 Q192R 基因型无关。
Eur Heart J. 2011 Jul;32(13):1605-13. doi: 10.1093/eurheartj/ehr155. Epub 2011 Apr 28.
8
9
Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.细胞色素 P450 2C19 失活多态性和主要人口统计学特征对择期冠状动脉支架置入术患者氯吡格雷负荷和维持治疗后残余血小板功能的影响。
J Am Coll Cardiol. 2010 Jun 1;55(22):2427-34. doi: 10.1016/j.jacc.2010.02.031.
10
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.常规评估氯吡格雷抵抗血小板活性和基因多态性在预测药物洗脱支架植入术后稳定型冠状动脉疾病患者的临床结局。
JACC Cardiovasc Interv. 2013 Nov;6(11):1166-75. doi: 10.1016/j.jcin.2013.06.010.

引用本文的文献

1
Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis.细胞色素P450 2C19*17等位基因变异对接受氯吡格雷治疗患者心血管和脑血管结局的影响:一项系统评价和荟萃分析。
J Res Med Sci. 2017 Sep 26;22:109. doi: 10.4103/jrms.JRMS_590_16. eCollection 2017.